• 제목/요약/키워드: Gene survival

검색결과 702건 처리시간 0.027초

구기자나무(Lycium chinense Mill.)로의 rolC유전자 도입에 미치는 요인 (Factors Affecting Introduction of rolC Gene in Lycium chinense Mill.)

  • 박용구;최명석;김병원;정원일;노광수
    • 식물조직배양학회지
    • /
    • 제22권6호
    • /
    • pp.329-334
    • /
    • 1995
  • 효과적인 형질전환 시스템을 이용하여 왜화유전자인 rolC 유전자를 구기자나무로의 형질전환 시스템을 확립하였다. 침으로 자극된 엽절편을 2.0 mg/L zeatin이 함유된 3/2 MS배지에 배양하였을 때 엽표면으로부터 줄기재분화가 되었다. 그러나 여러 농도의 kanamycin sulfate와 2.0 mg/L Aeatin이 함유된 배지에 엽절편을 배양하였을 때는 kanamycin sulfate의 농도가 증가할수록 줄기 유발수가 감소하는 것을 볼 수 있었으며, 적정선발농도는 10 mg/L이었다. 엽절편은 공동배양 시간에 따라서 생존율과 줄기재분화에 매우 큰 영향을 미쳤다. 엽절편의 생존율은 dipping할 경우가 가장 좋았으며, 배양시간이 길수록 엽절편의 백색화가 관찰되었고, 생존율이 급격히 감소하는 것을 볼 수 있었다. 줄기재분확에 가장 적합한 공동배양 시간은 24시간으로 나타났다. 공시균주와 24시간 동안 공동배양한 엽절편을 10mg/L의 kanamycin sulfate와 2.0 mg/L zeatin이 함유된 줄기 유도배지에 배양한 결과, 105개의 엽절편 중 80개의 엽절편이 생존하였으며, 그 중에서 15개의 재분화된 줄기를 얻었다. 재분화된 줄기들은 형질전환여부를 판명하기 위해 1차적으로 10 mg/L kanamycin sulfate가 함유된 배지에 옮겨 4 주간 배양한 결과, 항생제에 대해서 저항성을 가진 5개의 식물체를 선발할 수 있었다. 2차적으로 rolC유전자와 NPTII 유전자 도입의 유무를 검증하기 위하여 Southern 분석을 행한 결과, 구기자의 형질전환 식물체에서 rolC 유전자 probe의 coding sequence와 동일한 것으로 생각되는 1kb위치와 NPTII probe의 coding sequence와 동일한 것으로 생각되는 2.6kb 위치에서 각각의 밴드를 확인할 수 있었다.

  • PDF

Molecular diagnosis of spinal muscular atrophy

  • Lee, Ki-Sun;Hwang, Hee-Yu;Lee, Key-Hyoung;Park, Moon-Sung;Hahn, Si-Houn;Hong, Chang-Ho
    • Journal of Genetic Medicine
    • /
    • 제1권1호
    • /
    • pp.33-37
    • /
    • 1997
  • Spinal muscular atrophy (SMA) is the second most common fatal disease of childhood with autosomal dominant mode of inheritance, and in its less severe form the third most common neuromuscular disease of childhood after Duchenne muscular dystrophy. The genetic defect was found to be on the long arm of chromosome 5 (5q11.2-q13.3) where many genes and microsatellite markers were missing. One of the most important genes is the Survival Motor Neuron (SMN) gene which is homozygously missing in 90% of SMA patients. Another important gene, the Neuronal Apoptosis Inhibitory Protein (NAIP) gene was found to be defective in 67% of SMA type I patients. Studies so far suggest SMA occurs when the genes on the long arm of chromosome 5 are mutated or deleted. Recently our hospital encountered 2 SMA patients of type I and II respectively. These patients both had homozygously defective SMN genes but intact NAIP genes. We are reporting these cases with bibliographic review and discussion. Korean SMA patients presumably have defects in SMN genes similar to those found in European patients, although the significance of NAIP genes remains to be established. SMN gene defects can be easily diagnosed using PCR and restriction enzymes, and this method could be applied towards convenient prenatal diagnosis and towards screening for family members at risk.

  • PDF

Identification of vitro vulnificus lrp and Its Influence on Survival Under Various Stresses

  • Jeong, Hye-Sook;Rhee, Jee-Eun;Lee, Jeong-Hyun;Choi, Hyun-Kyung;Kim, Dae-Il;Lee, Myung-Hee;Park, Soon-Jung;Choi, Sang-Ho
    • Journal of Microbiology and Biotechnology
    • /
    • 제13권1호
    • /
    • pp.159-163
    • /
    • 2003
  • An lrp gene encoding a leucine-responsive regulatory protein was identified from Vitro vulnificus, and its role in the survival of the organism was assessed by analyzing the stress tolerance of the isogenic mutant, in which the lrp gene had been inactivated. The results demonstrated that Lrp contributes to the survival of V. vulnificus is dependent of the phase of growth.

Bayesian Variable Selection in the Proportional Hazard Model with Application to Microarray Data

  • Lee, Kyeong-Eun;Mallick, Bani K.
    • 한국통계학회:학술대회논문집
    • /
    • 한국통계학회 2005년도 춘계 학술발표회 논문집
    • /
    • pp.17-23
    • /
    • 2005
  • In this paper we consider the well-known semiparametric proportional hazards models for survival analysis. These models are usually used with few covariates and many observations (subjects). But, for a typical setting of gene expression data from DNA microarray, we need to consider the case where the number of covariates p exceeds the number of samples n. For a given vector of response values which are times to event (death or censored times) and p gene expressions(covariates), we address the issue of how to reduce the dimension by selecting the significant genes. This approach enables us to estimate the survival curve when n ${\ll}$p. In our approach, rather than fixing the number of selected genes, we will assign a prior distribution to this number. The approach creates additional flexibility by allowing the imposition of constraints, such as bounding the dimension via a prior, which in effect works as a penalty To implement our methodology, we use a Markov Chain Monte Carlo (MCMC) method. We demonstrate the use of the methodology to diffuse large B-cell lymphoma (DLBCL) complementary DNA (cDNA) data and Breast Carcinomas data.

  • PDF

An Application of the Clustering Threshold Gradient Descent Regularization Method for Selecting Genes in Predicting the Survival Time of Lung Carcinomas

  • Lee, Seung-Yeoun;Kim, Young-Chul
    • Genomics & Informatics
    • /
    • 제5권3호
    • /
    • pp.95-101
    • /
    • 2007
  • In this paper, we consider the variable selection methods in the Cox model when a large number of gene expression levels are involved with survival time. Deciding which genes are associated with survival time has been a challenging problem because of the large number of genes and relatively small sample size (n<

Bayesian Variable Selection in the Proportional Hazard Model with Application to DNA Microarray Data

  • Lee, Kyeon-Eun;Mallick, Bani K.
    • 한국생물정보학회:학술대회논문집
    • /
    • 한국생물정보시스템생물학회 2005년도 BIOINFO 2005
    • /
    • pp.357-360
    • /
    • 2005
  • In this paper we consider the well-known semiparametric proportional hazards (PH) models for survival analysis. These models are usually used with few covariates and many observations (subjects). But, for a typical setting of gene expression data from DNA microarray, we need to consider the case where the number of covariates p exceeds the number of samples n. For a given vector of response values which are times to event (death or censored times) and p gene expressions (covariates), we address the issue of how to reduce the dimension by selecting the significant genes. This approach enable us to estimate the survival curve when n < < p. In our approach, rather than fixing the number of selected genes, we will assign a prior distribution to this number. The approach creates additional flexibility by allowing the imposition of constraints, such as bounding the dimension via a prior, which in effect works as a penalty. To implement our methodology, we use a Markov Chain Monte Carlo (MCMC) method. We demonstrate the use of the methodology to diffuse large B-cell lymphoma (DLBCL) complementary DNA(cDNA) data.

  • PDF

A small carbohydrate fraction from Artemisia Folium suppresses death of the mouse thymocytes in vitro by down-regulating the Fas death receptor gene

  • Youn, Hyun-Joo;Chung, Hye-Kyung;Ji, Hee-Jung
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.131.2-132
    • /
    • 2003
  • Artemisia Folium is a preparation of dried leaves from Artemisia species and has been used traditionally to prevent or treat various kinds of woman's diseases. A similar preparation called Chinese Moxa has been used to treat rheumatism by moxibustion in Chinese medicine. A small carbohydrate fraction of approximately 1,000 dlaton from the water-soluble extract of the Artemisia Folium promoted survival of the mouse thymocytes in culture. A mouse gene array study suggested that the fraction might modulate Fas/FasL dependent apoptotic cell death and thus had influence on the survival of the thymocytes in culture. (omitted)

  • PDF

Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients

  • Khaleghian, Malihea;Shakoori, Abbas;Razavi, Amirnader Emami;Azimi, Cyrus
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권16호
    • /
    • pp.7061-7069
    • /
    • 2015
  • Background: During the past decades, the incidence and mortality rate of stomach cancer has demonstrated a great decrease in the world, but it is still one of the most common and fatal cancers especially among men worldwide, including Iran. The MYC proto-oncogene, which is located at 8q24.1, regulates 15% of genes and is activated in 20% of all human tumors. MYC amplification and overexpression of its protein product has been reported in 15-30% of gastric neoplasias. The aim of this investigation was to find the relative efficacy of CISH (chromogenic in situ hybridization) or IHC (immunohistochemistry) in diagnosis and prognosis of gastric cancer, as well as the relationship of amplification and expression of C-MYC gene with patient survival. Materials and Methods: In this cross-sectional study, 102 samples of gastric cancer were collected from patients who had undergone primary surgical resection at the Cancer Institute Hospital, Tehran University of Medical Sciences, from July 2009 to March 2014. All samples were randomly selected from those who were diagnosed with gastric adenocarcinomas. CISH and IHC methods were performed on all of them. Results: Patients were classified into two groups. The first consisted of stage I and II cases, and the second of stage III and IV. Survival tests for both groups was carried out with referrnce to CISH test reults. Group II (stage III & IV) with CISH+ featured lower survival than those with CISH- (p=0.233), but group I (stage I & II) patients demonstrated no significant variation with CISH+ or CISH- (p=0.630). Kaplan-Meier for both groups was carried out with IHC test findings and showed similar results. This data revealed that both diffuse and intestinal types of gastric cancer occurred significantly more in men than women. Our data also showed that CISH+ patients (43%) were more frequent in comparison with IHC+ patients (14.7%). Conclusions: For planning treatment of gastric cancer patients, by focusing on expanding tumors, which is the greatest concern of the surgeons and patients, CISH is a better and more feasible test than IHC, in regard to sensitivity and specificity. Therefore, CISH can be used as a feasible test for tumor growth and prognosis in stage III and IV lesions. This study also indicated that C-MYC amplification in gastric cancer is correlated with survival in advanced stages.

항혈관 1호의 항전이에 관한 연구 (Study on Anitmetastatic Effects of Antivascular-first)

  • 손창규;조종관;이승호
    • 동의생리병리학회지
    • /
    • 제16권1호
    • /
    • pp.133-140
    • /
    • 2002
  • To evaluate the anti metastatic effect of Antivascular-first(AntiV-F), we investigated cytotoxic effect on B16-F10 and HMCB. gene expression of MMP-9 and nm23-H1, and survival. After treating with AntiV-F, AntlV-F promoted cytotoxic effect on B16-F10 and HMCB as its density, compared with Control. AntiV-F inhibited gene expression of MMP-9 in the L+14 and HMCB cell line compared with Control. On the other hand AntiV-F increases gene expression of nm23-H1 and survival about 30% compared with Control. These results suggest that AntiV-F has effects on anti-metastasis can be used for treatment of cancer patients and preventing recurrence.

Predictive Value of XRCC1 and XRCC3 Gene Polymorphisms for Risk of Ovarian Cancer Death After Chemotherapy

  • Cheng, Chun-Xia;Xue, Min;Li, Kai;Li, Wu-Sheng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권6호
    • /
    • pp.2541-2545
    • /
    • 2012
  • Objective: To investigate any association between XRCC1 and XRCC3 polymorphisms and outcome of platinum-based chemotherapy in ovarian cancer patients. Methods: With a prospective study design was cases were consecutively collected from January 2005 to January 2007. All 310 included patients were followed-up until the end of January 2010. Genotyping of XRCC1 and XRCC3 polymorphisms was conducted by TaqMan Gene Expression assays. Results: A total of 191 patients died during follow-up. Our study showed a lower survival rate in XRCC1 399 Arg/Arg genotype than Gln/Gln, with a significant increased risk of death (HR=1.69, 95%CI=1.07-2.78). Similarly, those carrying XRCC3 Thr/Thr genotype had a increased risk as compare to the Met/Met genotype, with a HR (95% CI) of 1.90 (1.12-3.41). There was no significant association between XRCC1 Arg194Trp and XRCC1Arg280His gene polymorphisms and ovarian cancer death. Conclusion: Our study demonstrates that polymorphisms in DNA repair genes have roles in the susceptibility and survival of ovarian cancer patients.